Expert Ratings For Agios Pharmaceuticals
Expert Ratings For Agios Pharmaceuticals
Agios Pharmaceuticals的專家評級
Agios Pharmaceuticals (NASDAQ:AGIO) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去三個月中，Agios Pharmaceuticals（納斯達克：agios pharmaceuticals）已經被4位分析師分析，顯示出從看好到看淡的各種不同觀點。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近的評級概述，爲了全面了解過去30天的情緒變化並與前幾個月進行比較，提供了深入的見解。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $46.25, a high estimate of $53.00, and a low estimate of $33.00. This current average has increased by 30.91% from the previous average price target of $35.33.
分析師通過其12個月的價格目標評估提供更深入的見解，顯示平均目標爲46.25美元，高估值爲53.00美元，低估值爲33.00美元。這個當前平均值比先前的平均目標價格35.33美元增加了30.91%。
Breaking Down Analyst Ratings: A...
分析師評級...
登入免費觀看全文
登入/註冊